药品信息:
--------------------------------------------------------------- 详细处方信息以本药内容附件PDF文件(201922022585839.pdf)的“原文Priscribing Information”为准 --------------------------------------------------------------- 部分中文PROTONIX处方资料(仅供参考)
【英文名称】PROTONIX
【适用证】
与胃食管反流病(GERD)相关的糜烂性食管炎的短期治疗(1.1)
糜烂性食管炎愈合的维持(1.2)
包括Zollinger-Ellison(ZE)综合征在内的病理性高分泌性疾病(1.3)
【禁忌症】
已知对制剂的任何成分或取代的苯并咪唑过敏的患者(4)
接受含有rilpivirine产品的患者(4,7)
【用法用量】
与GERD相关的糜烂性食管炎的短期治疗(2.1)
成人:40毫克(每日一次,最多8周)
儿童(5岁及以上)
≥15kg至<40 kg:20 mg(每日一次,最多8周)
糜烂性食管炎愈合的维持(2.1)
成人:40毫克(每日一次)
包括Zollinger-Ellison综合征在内的病理性高分泌性疾病(2.1)
成人:40毫克(每日两次)
【INDICATIONS AND USAGE】
PROTONIX is a proton pump inhibitor (PPI) indicated for the following:
Short-Term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux Disease (GERD) (1.1)
Maintenance of Healing of Erosive Esophagitis (1.2)
Pathological Hypersecretory Conditions Including Zollinger-Ellison (ZE) Syndrome (1.3)
【DOSAGE AND ADMINISTRATION】
Short-Term Treatment of Erosive Esophagitis Associated With GERD (2.1)
Adults: 40 mg (Once Daily for up to 8 wks)
Children (5 years and older)
≥ 15 kg to < 40 kg: 20 mg (Once Daily for up to 8 wks)
Maintenance of Healing of Erosive Esophagitis (2.1)
Adults: 40 mg( Once Daily)
Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome (2.1)
Adults:40 mg (Twice Daily)
【CONTRAINDICATIONS】
Patients with known hypersensitivity to any component of the formulation or to substituted benzimidazoles (4)
Patients receiving rilpivirine-containing products (4,7)
--------------------------------------------------------------- 详细处方信息以本药内容附件PDF文件(201922022585839.pdf)的“原文Priscribing Information”为准 --------------------------------------------------------------- |